Study details
Enrolling now
Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically
University of California, Los Angeles
NCT IDNCT06370780ClinicalTrials.gov data as of Apr 2026
Target enrollment
1,000
Study length
about 4.2 years
Ages
18+
Locations
1 site in CA
About this study
This trial is testing a treatment called EPI LOVE to help people with HIV achieve and maintain viral suppression. The goal is to understand the factors that contribute to long-term viral suppression in different groups of people living with HIV, including those who are Black, use drugs, are young adults, or live in rural areas.
Based on ClinicalTrials.gov records.
What participants do
- 1.EPI LOVE
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low7%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Body systems
Immune, Infectious